Development of a high throughput equilibrium dialysis method

Journal of Pharmaceutical Sciences

Volumn 90, Issue 5, 2001, Pages 580-587

  Kariv, Ilona ^a   Cao, Hong ^a   Oldenburg, Kevin R ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Binding to plasma proteins; Equilibrium dialysis; High throughput screening

Indexed keywords

LOSARTAN; PAROXETINE; PLASMA PROTEIN; PROPRANOLOL;

ARTICLE; ASSAY; CONTROLLED STUDY; EQUILIBRIUM DIALYSIS; PROTEIN BINDING; VALIDATION PROCESS;

EID: 0035038596     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-6017(200105)90:5<580::AID-JPS1014>3.0.CO;2-4     Document Type: Article

References (24)

1. Combinatorial organic synthesis: Application to drug discovery
2. Current and future trends in high throughput screening for drug discovery
3. High-throughput pharmacokinetics: Cassette dosing
4. Novel technology to improve pharmaceutical productivity
5. Rational high-throughput screening in preclinical drug metabolism
6. Pharmacokinetics and metabolism in early drug discovery
7. High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds
8. Role of the development scientist in compound lead selection and optimization
9. Protein binding displacement interactions and their clinical importance
10. Protein binding as a primary determinant of clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs
11. Drug binding to human alpha-1-acid glycoprotien in health and disease
12. Protein binding of antimicrobials: Clinical pharmacokinetic and therapeutic implications
13. Influence of volume shifts on drug binding during equilibrium dialysis: Correction and attenuation
14. Factors affecting ultrafiltration-assessed values for drug binding
15. Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DUP753/MK954) and its pharmacologically active metabolite EXP3174
16. Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding
17. Variable binding of propranolol in human serum
18. Evaluation of a chiral stationary phase based on mixed immobilized proteins
19. Further characterization of specific drug binding sites on human serum albumin
20. Interactive binding to the two principal ligand binding sites of serum albumin: Effect of the neutral-to-base transition
21. Changes in the free (unbound) fraction of testosterone in serum in vitro as affected by pH and temperature
22. Differential binding of warfarin to maternal, foetal and non-pregnant sera and its clinical implications